LGCVX
Price
$19.68
Change
+$0.04 (+0.20%)
Updated
Sep 5 closing price
Net Assets
283.76M
RWIBX
Price
$71.98
Change
+$0.33 (+0.46%)
Updated
Sep 5 closing price
Net Assets
136.94B
Interact to see
Advertisement

LGCVX vs RWIBX

Header iconLGCVX vs RWIBX Comparison
Open Charts LGCVX vs RWIBXBanner chart's image
Lord Abbett Global Equity R5
Price$19.68
Change+$0.04 (+0.20%)
VolumeN/A
Net Assets283.76M
American Funds Capital World Gr&Inc R2
Price$71.98
Change+$0.33 (+0.46%)
VolumeN/A
Net Assets136.94B
LGCVX vs RWIBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LGCVX vs. RWIBX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGCVX is a StrongBuy and RWIBX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 137B vs. LGCVX (284M). RWIBX pays higher dividends than LGCVX: RWIBX (0.80) vs LGCVX (0.55). LGCVX was incepted earlier than RWIBX: LGCVX (9 years) vs RWIBX (23 years). RWIBX (1.51) and LGCVX (1.47) have similar cost to investors . LGCVX is a more actively managed with annual turnover of: 41.00 vs. RWIBX (27.00). LGCVX has a lower initial minimum investment than RWIBX: LGCVX (0) vs RWIBX (250). LGCVX annual gain was more profitable for investors over the last year : 21.92 vs. RWIBX (12.25). LGCVX return over 5 years is better than : 58.25 vs. RWIBX (43.09).
LGCVXRWIBXLGCVX / RWIBX
Total Expense Ratio0.651.5143%
Annual Report Gross Expense Ratio1.471.5197%
Fund Existence9 years23 years-
Gain YTD17.81615.601114%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets284M137B0%
Annual Yield % from dividends0.550.8069%
Returns for 1 year21.9212.25179%
Returns for 3 years71.4351.07140%
Returns for 5 years58.2543.09135%
Returns for 10 yearsN/A70.56-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRLD1.230.09
+7.89%
Prelude Therapeutics
MRNA25.140.86
+3.54%
Moderna
COGT13.050.11
+0.85%
Cogent Biosciences
WVVIP3.220.01
+0.31%
Willamette Valley Vineyards
YMAB8.580.01
+0.12%
Y-mAbs Therapeutics